Journal of Allergy and Clinical Immunology

259 Pages·2007·9.58 MB·English

Journal of Allergy and Clinical Immunology

Volume 119, Issue 3, Pages 527-766 (March 2007)

1. AAAAI Developing Researcher Award
Page A2
2. Nomination for AAAAI Award for Outstanding Research Published in the JACI by
a Developing Researcher
Page A3
3. This month's theme
Page A7
4. About the cover
Page A7
5. This month in Beyond Our Pages
Page A7
6. In-press articles
Page A8
7. Symbols used in the Table of Contents
Page A8
8. Editorial Board
Page A20
Reader services
9. Information for Readers
Page A26
10. Newsview-AAAAI
Pages A31-A32
11. CME Activities Calendar
Pages A37-A38
12. Information for category 1 CME Credit
Page A42
Editors' choice
13. The Editors' Choice
Pages 527-528
Donald Y.M. Leung, Harold S. Nelson and Stanley J. Szefler
Reviews and feature articles

Current reviews of allergy and clinical immunology/Series
14. Signal transducer and activator of transcription signals in allergic disease
Pages 529-541
Weiguo Chen and Gurjit K. Khurana Hershey
Continuing Medical Education examination
15. Signal transducer and activator of transcription signals in allergic disease
Pages 542-543
Molecular mechanisms in allergy and clinical immunology/Series
16. Proximal signaling events in Fc RI-mediated mast cell activation
Pages 544-552
Taku Kambayashi and Gary A. Koretzky
Continuing Medical Education examination
17. Proximal signaling events in Fc RI-mediated mast cell activation
Pages 553-554
Editorial
18. Understanding the intricate network of signaling molecules
Pages 555-557
Javier Chinen and William T. Shearer
Asthma diagnosis and treatment

Advances in Asthma, Allergy, and Immunology Series 2007
19. Advances in pediatric asthma 2006
Pages 558-562
Stanley J. Szefler
20. Advances in adult asthma 2006: Its risk factors, course, and management
Pages 563-566
Andrea J. Apter
Editorial
21. Should corticosteroids be used for first-time young wheezers?
Pages 567-569
Miles Weinberger
Original articles
22. Prednisolone reduces recurrent wheezing after a first wheezing episode associated
with rhinovirus infection or eczema
Pages 570-575
Pasi Lehtinen, Aino Ruohola, Timo Vanto, Tytti Vuorinen, Olli Ruuskanen and
Tuomas Jartti
23. Use of short-acting β2-agonists during pregnancy and the risk of pregnancy-
induced hypertension
Pages 576-582
Marie-Josée Martel, Évelyne Rey, Marie-France Beauchesne, Sylvie Perreault,
Amélie Forget, Karim Maghni, Geneviève Lefebvre and Lucie Blais
24. Air trapping in mild and moderate asthma: Effect of inhaled corticosteroids
Pages 583-590
José-Manuel Tunon-de-Lara, François Laurent, Violaine Giraud, Thierry Perez,
Bernard Aguilaniu, Houari Meziane, Armelle Basset-Merle and Pascal Chanez
25. Excessive body weight is associated with additional loss of quality of life in
children with asthma
Pages 591-596
René van Gent, Cornelis K. van der Ent, Maroeska M. Rovers, Jan L.L. Kimpen,
Liesbeth E.M. van Essen-Zandvliet and Gea de Meer
26. Sleep apnea is associated with bronchial inflammation and continuous positive
airway pressure–induced airway hyperresponsiveness
Pages 597-603
Gilles Devouassoux, Patrick Lévy, Eliane Rossini, Isabelle Pin, Michèle Fior-
Gozlan, Mireille Henry, Daniel Seigneurin and Jean-Louis Pépin
27. Severe intermittent wheezing in preschool children: A distinct phenotype
Pages 604-610
Leonard B. Bacharier, Brenda R. Phillips, Gordon R. Bloomberg, Robert S.
Zeiger, Ian M. Paul, Marzena Krawiec, Theresa Guilbert, Vernon M. Chinchilli
and Robert C. Strunk
28. Inhaled steroids are associated with reduced lung function decline in subjects with
asthma with elevated total IgE
Pages 611-617
Roberto de Marco, Alessandro Marcon, Deborah Jarvis, Simone Accordini,
Massimiliano Bugiani, Lucia Cazzoletti, Isa Cerveri, Angelo Corsico, David
Gislason, Amund Gulsvik, et al.
29. Safety of leukotriene receptor antagonists in pregnancy
Pages 618-625
Ludmila N. Bakhireva, Kenneth Lyons Jones, Michael Schatz, Hillary S. Klonoff-
Cohen, Diana Johnson, Donald J. Slymen and Christina D. Chambers
Mechanisms of asthma and allergic inflammation
30. Relationship between spleen tyrosine kinase and phosphatidylinositol 5′
phosphatase expression and secretion from human basophils in the general
population
Pages 626-633
Jr., Donald W. MacGlashan
31. Adiposity, asthma, and airway inflammation
Pages 634-639
Christene R. McLachlan, Richie Poulton, George Car, Jan Cowan, Susan Filsell,
Justina M. Greene, D. Robin Taylor, David Welch, Avis Williamson, Malcolm R.
Sears, et al.
32. Cat IgA, representative of new carbohydrate cross-reactive allergens
Pages 640-645
Justus Adédoyin, Hans Grönlund, Hans Öman, S.G.O. Johansson and Marianne
van Hage
33. Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase–
induced signal by intrapulmonary administration of antioxidants blocks allergic
airway inflammation
Pages 646-653
Nilesh Dharajiya, Barun K. Choudhury, Attila Bacsi, Istvan Boldogh, Rafeul Alam
and Sanjiv Sur
34. Sensitization to Ascaris lumbricoides and severity of childhood asthma in Costa
Rica
Pages 654-661
Gary M. Hunninghake, Manuel E. Soto-Quiros, Lydiana Avila, Ngoc P. Ly,
Catherine Liang, Jody S. Sylvia, Barbara J. Klanderman, Edwin K. Silverman and
Juan C. Celedón
35. T-bet inhibits both TH2 cell–mediated eosinophil recruitment and TH17 cell–
mediated neutrophil recruitment into the airways
Pages 662-670
Michio Fujiwara, Koichi Hirose, Shin-ichiro Kagami, Hiroaki Takatori, Hidefumi
Wakashin, Tomohiro Tamachi, Norihiko Watanabe, Yasushi Saito, Itsuo Iwamoto
and Hiroshi Nakajima
36. Skin inflammation in RelB−/− mice leads to defective immunity and impaired
clearance of vaccinia virus
Pages 671-679
Eva-Jasmin Freyschmidt, Clinton B. Mathias, Daniel H. MacArthur, Amale
Laouar, Manjunath Narasimhaswamy, Falk Weih and Hans C. Oettgen
37. TNF can contribute to multiple features of ovalbumin-induced allergic
inflammation of the airways in mice
Pages 680-686
Susumu Nakae, Carolina Lunderius, Lien H. Ho, Beatrix Schäfer, Mindy Tsai and
Stephen J. Galli
Environmental and occupational respiratory disorders
38. TNF polymorphism and bronchoalveolar lavage cell TNF-α levels in chronic
beryllium disease and beryllium sensitization
Pages 687-696
Hiroe Sato, Lori Silveira, Tasha Fingerlin, Karen Dockstader, May Gillespie, Anna
L. Lagan, Penny Lympany, Richard T. Sawyer, Roland M. du Bois, Kenneth I.
Welsh, et al.
39. Cat and dust mite allergen levels, specific IgG and IgG4, and respiratory symptoms
in adults
Pages 697-704
Deborah Jarvis, Jan-Paul Zock, Joachim Heinrich, Cecilie Svanes, Giuseppe
Verlato, Mario Olivieri, Simona Villani, Michela Ponzio, Benedicte Leynaert,
Jordi Sunyer, et al.
Food allergy, anaphylaxis, dermatology, and drug allergy
40. Activation of the tissue factor pathway of blood coagulation in patients with
chronic urticaria
Pages 705-710
Riccardo Asero, Alberto Tedeschi, Raffaella Coppola, Samantha Griffini, Paolo
Paparella, Piersandro Riboldi, Angelo V. Marzano, Daniele Fanoni and Massimo
Cugno
41. Incomplete digestion of codfish represents a risk factor for anaphylaxis in patients
with allergy
Pages 711-717
Eva Untersmayr, Helle Vestergaard, Hans-Jørgen Malling, Louise Bjerremann
Jensen, Michael H. Platzer, George Boltz-Nitulescu, Otto Scheiner, Per Stahl
Skov, Erika Jensen-Jarolim and Lars K. Poulsen
42. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that
of asthma: Three-year results of the German Infant Nutritional Intervention Study
Pages 718-725
Andrea von Berg, Sibylle Koletzko, Birgit Filipiak-Pittroff, Birgit Laubereau,
Armin Grübl, Heinz-Erich Wichmann, Carl-Peter Bauer, Dietrich Reinhardt and
Dietrich Berdel
43. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity
Pages 726-730
Vanessa Leguy-Seguin, Genevieve Jolimoy, Bruno Coudert, Corine Pernot, Sophie
Dalac, Pierre Vabres and Evelyne Collet
44. Pediatric patients with eosinophilic esophagitis: An 8-year follow-up
Pages 731-738
Amal H. Assa'ad, Philip E. Putnam, Margaret H. Collins, Rachel M. Akers, Sean
C. Jameson, Cassie L. Kirby, Bridget K. Buckmeier, Jennifer Z. Bullock, Ann R.
Collier, Michael R. Konikoff, et al.
Basic and clinical immunology

Rostrum
45. Suppressor of cytokine signaling in allergic inflammation
Pages 739-745
Judit Knisz and Paul B. Rothman
46. Correction
Page 745
Letters to the Editor
47. Contamination of probiotic preparations with milk allergens can cause anaphylaxis
in children with cow's milk allergy
Pages 746-747
Tzu-Tai Tiger Lee, Martine Morisset, Catherine Astier, Denise-Anne Moneret-
Vautrin, Vanina Cordebar, Etienne Beaudouin, Fanny Codreanu, Bernard E.
Bihain and Gisèle Kanny
48. Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2
(PRO 542) observed in HIV-1–infected children
Pages 747-750
Courtney V. Fletcher, Jaime G. DeVille, Pearl M. Samson, Jr., John H. Moye,
Joseph A. Church, Hans M.L. Spiegel, Paul Palumbo, Terence Fenton, M.
Elizabeth Smith, Bobbie Graham, et al.
49. Prevalence of asthma in children and young adults with HIV infection
Pages 750-752
Samuel B. Foster, Mary E. Paul, Claudia A. Kozinetz, Charles G. Macias and
William T. Shearer
50. Successful treatment of delayed pressure urticaria with anti–TNF-α
Pages 752-754
Markus Magerl, Sandra Philipp, Maria Manasterski, Markus Friedrich and Marcus
Maurer
Correspondence
51. What's in a kiss: Peanut allergen transmission as a sensitizer?
Page 755
Richard C. Nolan, Maria P. de Leon, Jennifer M. Rolland, Richard K.S. Loh and
Robyn E. O'Hehir
52. Drugs may also induce allergic reactions in sensitized individuals through
passionate kissing
Page 756
Gennaro Liccardi and Gennaro D'Amato
53. Reply
Pages 756-757
Jennifer M. Maloney and Scott H. Sicherer
54. Evidence for allergic reactions in isocyanate asthma
Pages 757-758
Xaver Baur
55. Reply
Page 758
Meinir Jones, Alison Floyd, Kayhan T. Nouri-Aria, Mikila R. Jacobson, Stephen
R. Durham, Anthony Newman Taylor and Paul Cullinan
56. Washing the cat requires shampoo
Page 758
David W. Goetz
57. Reply
Pages 758-759
Christian Gallus Nageotte
58. “Black box” warnings and drug surveillance
Page 759
Rogelio Menendez
59. Reply
Pages 759-760
Donald W. Aaronson
Images in allergy and immunology
60. Transcription factors in allergic diseases
Pages 761-764
David Préfontaine, Pierre-Olivier Fiset and Qutayba Hamid
Beyond our pages
61. Beyond Our Pages
Pages 765-766
Burton Zweiman and Marc E. Rothenberg
2A AAAAI Developing Researcher Award J ALLERGY CLIN IMMUNOL
MARCH 2007
The most frequently cited allergy/immunology journal in the
field, The Journal of Allergy and Clinical Immunology, con-
tinues to grow in prominence because of the excellent research
it showcases. The Academy is proud to announce this new JACI Award
which will recognize innovative research and outstanding scientific
writing by the new generation of allergy researchers and clinicians.
The AAAAI Award for Outstanding Research Published in the JACI by
a Developing Researcher provides an unrestricted prize of $1,500, com-
memorative plaque, and recognition during the AAAAI’s Annual Busi-
ness Meeting. Up to 4 awardees will be chosen during one calendar year.
Objective
• To encourage the submission to JACI of the highest quality articles on our science’s frontier
• To recognize ground breaking research and excellent writing by the new generation of allergy researchers
and clinicians
Award
• Formal presentation of an unrestricted prize of $1500 and a plaque for each award (funded by the AAAAI) will be
made at the annual Academy Meeting
• Announcement of the awards for the year will be featured in the published program for the annual Academy
Meeting
• Announcement and commendation of winners will be published in the Journal
Title of the Award
• The AAAAI Award for Outstanding Research Published in the JACI by a Developing Researcher
Judgment Process
• A chairman will be appointed by the JACI Editors to coordinate a panel whose task will be to review and
evaluate nominated papers and reach a decision on recipients of the award
• Judgement will be by a panel composed of the chairman of the award committee, one Editor, and at least two
researchers or clinicians who are knowledgeable in the area of research being reported
Conditions of Eligibility
• Candidates must meet the following criteria for eligibility
—can be from any training program world-wide
—must have completed an MD and/or PhD or the equivalent within the 7 years prior to nomination for the
award
—must have conducted the research and written the paper during the post-doctoral fellowship training and not
while holding a faculty position
• The research must be considered outstanding and represent a conceptual advance in the treatment or pathogenesis
of allergic disease
• The article must have been published in JACI
• The article must have appeared within 12 months of the nomination
• The candidate must have conducted the majority of the research or have been the primary leader of the research
team and appear as the first author
• A written nomination of the candidate and paper must be submitted by a sponsor (the training director, preceptor,
research mentor, or a current Editor of the Journal.) The sponsor must submit a completed Nomination Applica-
tion Form, a statement briefly discussing the impact of the scientific observations on the field of allergy and
immunology and justification of why the published work is deserving of the award, and 3 letters of recommen-
dation for the nominated paper, 2 of which are from individuals at institutions with which the fellow has never
been associated. (Letters should address the significance and importance of the work in the paper and its relevance
to the fellow’s body of work, the quality of the written presentation, the fellow’s personal characteristics and
potential for a future in academic medicine.)
• Up to 4 awards may be given within each calendar year; if no candidates are deemed of sufficient merit, no award
will be given
Criteria for Excellence in a Publication
• The publication must present novel information that holds significant importance for the basic and clinical science
of allergy, asthma or immunology
• The article must meet the highest standards for scientific writing
• The publication must represent a significant portion of the candidate’s fellowship work
*For application forms and further information, please contact the Editorial Office at 303 398-1963.
J ALLERGY CLIN IMMUNOL AAAAI Developing Researcher Award 3A
VOLUME 119, NUMBER 3
Nomination for AAAAI Award for Outstanding Research
Published in the JACI by a Developing Researcher
SPONSOR Name Date
Relationship to FIT:______TPD/Preceptor__________Research Mentor________JACI Editor
DEVELOPING RESEARCHER Name
Mailing Address Phone Fax
Country E-mail
Academic affiliation
Academic degree(s) Date degree(s) awarded
Faculty appointments Appointment date(s)
Training program where work on paper was completed Date of Training ____ to ____
Article submitted for consideration (MUST HAVE BEEN ACCEPTED FORJACIPUBLICATION)
(Provide title, authors & complete publication reference; if in press, provide planned publication date)
Attach 3 copies of the published article; if the article is “in press,” provide 2 copies of the manuscript, illustrations, and tables)
3 Letters of recommendation provided by Academic affiliation:
(Name and address)
1. 1.
2. 2.
3. 3.
(Attach the original copy of each letter in a sealed envelope. At least 2 letters should be provided by individuals who are not asso-
ciated with the nominee’s training program)
Attach a typewritten statement, no longer than 2 paragraphs, identifying the significance of the scientific observations in
this publication and explaining why this published work is deserving of the AAAAI Developing Researcher publication award